Proteasome inhibition: a new approach for the treatment of malignancies.
about
Enteropeptidase: a gene associated with a starvation human phenotype and a novel target for obesity treatmentA phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapyTreatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccinationCellular DNA repair cofactors affecting hepatitis B virus infection and replication.Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells.
P2860
Proteasome inhibition: a new approach for the treatment of malignancies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Proteasome inhibition: a new approach for the treatment of malignancies.
@ast
Proteasome inhibition: a new approach for the treatment of malignancies.
@en
type
label
Proteasome inhibition: a new approach for the treatment of malignancies.
@ast
Proteasome inhibition: a new approach for the treatment of malignancies.
@en
prefLabel
Proteasome inhibition: a new approach for the treatment of malignancies.
@ast
Proteasome inhibition: a new approach for the treatment of malignancies.
@en
P2093
P50
P1433
P1476
Proteasome inhibition: a new approach for the treatment of malignancies
@en
P2093
Jacques-Olivier Bay
Jean-Philippe Spano
Jean-Yves Blay
Olivier Rixe
P304
E61-6, 945-52
P577
2005-11-01T00:00:00Z